3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
There are many ways to make money on Wall Street, but some methods are a lot more reliable than others. Whether you're ...
appliedclinicaltrialsonline16h
ASTRO Trial Shows SC Tremfya Provides Significant Clinical Benefits in Moderately to Severely Active Ulcerative Colitis
Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...
Opinion
Bradford Era18hOpinion
Cancer drug costs nearly $200K
Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according ...
Cancer Stocks Enter A Defining Year As Innovation Surges In 2025
New Diagnostics, AI Breakthroughs, and Next-Gen Therapies Are Transforming the Oncology Market. The oncology sector is experiencing <stron ...
Why Pfizer's Stock Price Isn't Reflecting Its True Value
Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...
2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
appliedclinicaltrialsonline4d
Five-Year POETYK PSO Trial Results Show Sustained Efficacy, Safety with Sotyktu for Moderate-to-Severe Plaque Psoriasis
Five-year data from the POETYK PSO long-term extension trial confirm the sustained efficacy and safety of Sotyktu ...